Can a simple test predict stomach cancer return?
NCT ID NCT04665687
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is collecting tissue and blood samples from 1,730 people with early gastric cancer or precancerous stomach growths. Researchers will analyze the genetic profiles of these samples to find markers that could help diagnose these conditions early and predict if the cancer might come back after treatment. The goal is to improve personalized care for patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to better ways to diagnose early gastric cancer and predict which patients might have a recurrence after treatment.
- What could go wrong
- This is an observational study, not a treatment trial. It may not directly benefit participants, and the markers identified may not prove useful in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Samsung medical center
RECRUITINGSeoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which treatment for early stomach cancer offers the best Long-Term survival?
- Stomach bug clues: can infection patterns forecast early cancer behavior?
- Fluorescent dye guides Stomach-Sparing surgery for early cancer
- New Dual-Scope surgery shows promise for early stomach cancer
- AI could help endoscopists catch stomach cancer earlier
- New laser probe could spot stomach cancer earlier than biopsy